Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen M Westerhout

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Nucleic Acids Research|June 20, 2007
A systematic analysis of the effect of target RNA structure on RNA interferenceEllen M Westerhout, Ben Berkhout
Nature Biotechnology|December 11, 2007
RNA interference against viruses: strike and counterstrikeJoost Haasnoot, Ellen M Westerhout, Ben Berkhout
Retrovirology|September 5, 2006
The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interferenceEllen M Westerhout, Olivier ter Brake, Ben Berkhout
Retrovirology|April 29, 2008
HIV-1 latency in actively dividing human T cell linesRienk E Jeeninga, Ellen M Westerhout, Marja L van Gerven, et al.
Nucleic Acids Research|February 3, 2005
HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genomeEllen M Westerhout, Marcel Ooms, Monique Vink, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2006
A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replicationEllen M Westerhout, Monique Vink, P C Joost Haasnoot, et al.
Immunogenetics|November 20, 2002
Viral immune evasion: a masterpiece of evolutionMireille T M Vossen, Ellen M Westerhout, Cécilia Söderberg-Nauclér, et al.
Cancer Research|February 5, 2013
FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastomaEvan E Santo, Peter Stroeken, Peter V Sluis, et al.
Journal of Virology|February 14, 2004
Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibitionAtze T Das, Thijn R Brummelkamp, Ellen M Westerhout, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 10, 2015
Liquid chromatography-tandem mass spectrometric assay for the PI3K/mTOR inhibitor GSK2126458 in mouse plasma and tumor homogenateM Emmy M Dolman, Ellen M Westerhout, Mohamed Hamdi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Nucleic Acids Research|June 20, 2007
A systematic analysis of the effect of target RNA structure on RNA interferenceEllen M Westerhout, Ben Berkhout
Nature Biotechnology|December 11, 2007
RNA interference against viruses: strike and counterstrikeJoost Haasnoot, Ellen M Westerhout, Ben Berkhout
Retrovirology|September 5, 2006
The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interferenceEllen M Westerhout, Olivier ter Brake, Ben Berkhout
Retrovirology|April 29, 2008
HIV-1 latency in actively dividing human T cell linesRienk E Jeeninga, Ellen M Westerhout, Marja L van Gerven, et al.
Nucleic Acids Research|February 3, 2005
HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genomeEllen M Westerhout, Marcel Ooms, Monique Vink, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2006
A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replicationEllen M Westerhout, Monique Vink, P C Joost Haasnoot, et al.
Immunogenetics|November 20, 2002
Viral immune evasion: a masterpiece of evolutionMireille T M Vossen, Ellen M Westerhout, Cécilia Söderberg-Nauclér, et al.
Cancer Research|February 5, 2013
FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastomaEvan E Santo, Peter Stroeken, Peter V Sluis, et al.
Journal of Virology|February 14, 2004
Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibitionAtze T Das, Thijn R Brummelkamp, Ellen M Westerhout, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 10, 2015
Liquid chromatography-tandem mass spectrometric assay for the PI3K/mTOR inhibitor GSK2126458 in mouse plasma and tumor homogenateM Emmy M Dolman, Ellen M Westerhout, Mohamed Hamdi, et al.
Pageof 3